Linking claims data to EHRs for metastatic breast cancer patients improves diagnosis coverage and adverse event detection but reduces sample size and underrepresents patients 65 years. Age-stratified analyses…

A national study shows that lapses in PDR care are frequent and tied to vision loss. Identifies key risk factors and stresses the importance of regular follow-up.

This comparative-effectiveness study of 48,165 individuals with type 2 diabetes initiating second-line therapy found that treatment with glipizide was associated with a modestly higher 5-year risk of major…

Apalutamide leads to faster, deeper PSA90 response vs enzalutamide in real-world patients with de novo metastatic castration-sensitive prostate cancer.

Real-world study shows apalutamide leads to faster, deeper PSA90 response vs abiraterone in patients with de novo metastatic castration-sensitive prostate cancer.

This retrospective study analyzes people with type 1 diabetes using CGM linked to electronic health records, revealing persistent hypoglycemic events and suboptimal glycemic control over time, underscoring the…

Real-world data shows poor survival outcomes (

Survival outcomes associated with different androgen receptor pathway inhibitors (ARPIs) prescribed for the treatment of metastatic castration (hormone)-sensitive prostate cancer (mCSPC) have not been directly compared. The objective…